Eyenovia Reports Third Quarter 2019 Financial Results
November 13, 2019 16:05 ET
|
Eyenovia, Inc.
NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
Eyenovia Announces Conference Call and Webcast for Third Quarter 2019 Financial Results
October 31, 2019 08:30 ET
|
Eyenovia, Inc.
NEW YORK, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
Eyenovia Advances MicroLine for the Treatment of Presbyopia Towards Phase III Development and Reprioritizes Late-Stage Ophthalmology Pipeline
October 29, 2019 16:05 ET
|
Eyenovia, Inc.
Defers development activities of MicroProst and MicroTears Company to host conference call on Tuesday, October 29, 2019 at 5:00 pm ET NEW YORK, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc....
Eyenovia to Participate in Multiple Upcoming Medical Meetings
October 02, 2019 08:30 ET
|
Eyenovia, Inc.
NEW YORK, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
Eyenovia to Present at Two Upcoming Investor Conferences
September 03, 2019 08:30 ET
|
Eyenovia, Inc.
NEW YORK, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
Eyenovia Reports Second Quarter 2019 Financial Results
August 12, 2019 16:05 ET
|
Eyenovia, Inc.
NEW YORK, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
Eyenovia Announces Conference Call and Webcast for Second Quarter 2019 Financial Results
August 06, 2019 08:30 ET
|
Eyenovia, Inc.
NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
Eyenovia, Inc. Announces Underwriters’ Full Exercise of Over-Allotment Option in Public Offering
July 16, 2019 16:05 ET
|
Eyenovia, Inc.
NEW YORK, July 16, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
Eyenovia, Inc. Announces Closing of Public Offering
July 15, 2019 16:30 ET
|
Eyenovia, Inc.
NEW YORK, July 15, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
Eyenovia, Inc. Prices Public Offering of Common Stock
July 11, 2019 09:00 ET
|
Eyenovia, Inc.
NEW YORK, July 11, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...